Life ScienceCompany
C3 Cannabinoid Compound Ownership
Who owns C3 Cannabinoid Compound?
C3 Cannabinoid Compound is owned by Dermapharm Holding SE. It was acquired on December 15, 2021.
C3 Cannabinoid Compound Business Overview
Where is C3 Cannabinoid Compound headquartered?
C3 Cannabinoid Compound is headquartered in Neumarkt, Germany.
What sector is C3 Cannabinoid Compound in?
C3 Cannabinoid Compound is a life science company.
Life Science M&A Summary in 2021
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.
Join Mergr to view all 398 acquisitions of life science companies in 2021, including 46 acquisitions by private equity firms, and 352 by strategics.